By Comparing TPF Induction Chemotherapy Combined With Nimotuzumab Concurrent Radiotherapy and Cisplatin Concurrent Radio-chemotherapy for Locally Advanced NPC

Condition:   Nasopharyngeal Carcinoma
Interventions:   Drug: Nimotuzumab;   Drug: Cisplatin
Sponsor:   Guiyang Medical University
Recruiting

https://ift.tt/2HMN2jb